Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D09ICH
|
|||
| Drug Name |
CD7.CAR/28zeta CAR T cells
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | B-cell acute lymphoblastic leukaemia [ICD-11: 2B33.3; ICD-10: C91, C91.9] | Phase 1 | [1] | |
| Cutaneous T-cell lymphoma [ICD-11: 2B01; ICD-10: C84.0] | Phase 1 | [1] | ||
| Non-hodgkin lymphoma [ICD-11: 2B33.5; ICD-10: C85.9] | Phase 1 | [1] | ||
| Company |
Baylor College of Medicine
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | T-cell antigen CD7 (CD7) | Target Info | CAR-T-Cell-Therapy | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03690011) Cell Therapy for High Risk T-Cell Malignancies Using CD7-Specific CAR Expressed On Autologous T Cells | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.